Characterization of systemic therapy utilization in 274 patients with de novo metastatic breast cancer and effect of novel chemotherapeutic agents on survival.
R. A. Nelson
No relevant relationships to disclose
J. E. Mortimer
No relevant relationships to disclose
M. E. Dehaven
No relevant relationships to disclose
S. Onami
No relevant relationships to disclose
L. Bernstein
No relevant relationships to disclose
S. K. Pal
No relevant relationships to disclose